Back to discover
Drug
4-Cresol
Research stageEmerging research
Also known as PARA-CRESOL.
2
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2023-08-01European heart journal
Research2023-07-18Frontiers in endocrinology
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
4-Cresol
Aliases & brands
PARA-CRESOL
RxNorm CUI
2467144
ChEMBL ID
CHEMBL16645
UNII
1MXY2UM8NV
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Most influential
Major research themes4
Cresols1Gastrointestinal Microbiome1Glucagon-Like Peptide 11Myocardial Infarction1
Journals, researchers & institutions
Top journals
- European heart journal1
- Frontiers in endocrinology1
Leading researchers
- Bäckhed F2
- Arora T1
- Buffa JA1
- Demuth I1
- Fischbach MA1
- Gillum MP1
- Haghikia A1
- Hazen SL1
Leading institutions
free-text, unnormalised
- Wallenberg Laboratory2
- and Thoracic Institute1
- Biomedical Innovation Academy1
- Center for Microbiome & Human Health1
- Center for Regenerative Therapies1
- Charité-Universitätsmedizin Berlin1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature